FDA: Drugs From The Compounding Shop May Be Contaminated

Based on a recent inspection, the FDA is warning providers and hospital supply managers that drugs produced and distributed by The Compounding Shop in St. Petersburg, Fla., may not be sterile, according to the American Society of Anesthesiologists.

Advertisement

No products from this compounder that are marked as sterile should be administered to patients, as microbial contamination can put patients at risk for severe infections.

Hospitals and healthcare providers should quarantine any such products and await further instructions, according to the release.

More Articles on Anesthesia:
Maquet’s SERVO-i Ventilator Battery Module Given Class 1 Recall
FDA: Pregnant Women Should Avoid Valproate Drug for Migraine Prevention
Masimo Rainbow Respiratory Monitor Cleared by FDA for Pediatric Use

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

  • As the shortage of physician anesthesiologists across the U.S. becomes more severe, certified-registered nurse anesthetists have emerged as an essential…

  • As of April 6, 2026, CRNAs’ average annual salary is $276,434, according to salary transparency platform Marit Health’s compilation of…

Advertisement

Comments are closed.